Table 1.
Candidate genes associated with HCV spontaneous clearance or response to therapy | |||
---|---|---|---|
Gene symbol | Chromosome location | Gene name | Number of SNPs in analysis |
IL28B | 19q13.13 | Interleukin 28B (encoding IFN-gamma-3) | 4 |
SOCS3 | 17q25.3 | Suppressor of cytokine signaling 3 | 16 |
SOCS1 | 16p13.13 | Suppressor of cytokine signaling 1 | 2 |
IL-10 | 1q31-q32 | Interleukin 10 | 15 |
IL-18 | 11q22.2-q22.3 | Interleukin 18 | 6 |
TNF-alpha | 6p21.3 | Tumor necrosis factor alpha | 1 |
TGF-beta-1 | 19q13.1 | Transforming growth factor, beta 1 | 4 |
IL-6 | 7p21 | Interleukin 6 | 42 |
CTLA-4 | 2q33 | Cytotoxic T-lymphocyte-associated protein 4 | 7 |
IFNG | 12q14 | Interferon, gamma | 8 |
HLA genes: | |||
HLA-DRB1 | 6p21.3 | Major histocompatibility complex, class II, DR beta 1 | 5 |
HLA-DQB1 | 6p21.3 | Major histocompatibility complex, class II, DQ beta 1 | 40 |